{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:20:48Z","timestamp":1781076048003,"version":"3.54.1"},"reference-count":24,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1422,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1111\/j.1346-8138.2011.01278.x","type":"journal-article","created":{"date-parts":[[2011,10,10]],"date-time":"2011-10-10T17:05:33Z","timestamp":1318266333000},"page":"1153-1157","source":"Crossref","is-referenced-by-count":6,"title":["Hepatotoxicity and liver enzyme alteration in patients with immunobullous diseases receiving immunosuppressive therapy"],"prefix":"10.1111","volume":"38","author":[{"given":"Mostafa M.","family":"SHAHSHAHANI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"AZIZAHARI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahere","family":"SOORI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"MANAVI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"BALIGHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"DANESHPAZHOOH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheida S.","family":"DAVATCHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasife","family":"ESMAILI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,10,10]]},"reference":[{"issue":"9479","key":"10.1111\/j.1346-8138.2011.01278.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(05)66829-8","article-title":"Pemphigus","volume":"366","author":"Bystryn","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1111\/j.1346-8138.2011.01278.x-BIB2|cit2","first-page":"90","article-title":"A Review on - Pemphigus vulgaris: Unnecessary Immunity","volume":"1","author":"Choudhary","year":"2010","journal-title":"International Journal of Pharmaceutical and Biological Archives"},{"issue":"5","key":"10.1111\/j.1346-8138.2011.01278.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2036.2006.02980.x","article-title":"Review article: thiopurins in inflammatory bowel disease","volume":"24","author":"Derijks","year":"2006","journal-title":"Alimentary Pharmacology and Therapeutic"},{"issue":"7","key":"10.1111\/j.1346-8138.2011.01278.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/j.1572-0241.2007.01187.x","article-title":"Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review","volume":"102","author":"Gisbert","year":"2007","journal-title":"The American journal of Gastroenterology"},{"issue":"8","key":"10.1111\/j.1346-8138.2011.01278.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/pds.926","article-title":"Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease","volume":"13","author":"Gearry","year":"2004","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"4","key":"10.1111\/j.1346-8138.2011.01278.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2230.1995.tb01343.x","article-title":"Azathioprine hypersensitivity-like reations--a case report and a review of the literature","volume":"20","author":"Knowles","year":"1995","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1111\/j.1346-8138.2011.01278.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0190-9622(08)81207-8","article-title":"Azathioprine hypersensitivity in bullous pemphigoid","volume":"23","author":"Collison","year":"1990","journal-title":"J Am Acad Dermatol"},{"issue":"9433","key":"10.1111\/j.1346-8138.2011.01278.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0140-6736(04)16808-6","article-title":"Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial","volume":"364","author":"Remuzzi","year":"2004","journal-title":"The Lancet"},{"key":"10.1111\/j.1346-8138.2011.01278.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1345\/aph.1H171","article-title":"Methylprednisolone-induced toxic hepatitis","volume":"40","author":"Topal","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1346-8138.2011.01278.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejim.2004.10.018","article-title":"Acute hepatitis related to prednisolone","volume":"16","author":"Hofstee","year":"2005","journal-title":"European Journal of Internal Medicine"},{"issue":"1","key":"10.1111\/j.1346-8138.2011.01278.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/WNF.0b013e3181bbf3a7","article-title":"Hepatotoxicity After High-Dose Methylprednisolone for Demyelinating Disease","volume":"33","author":"Loraschi","year":"2010","journal-title":"Clinical Neuropharmacology"},{"issue":"2","key":"10.1111\/j.1346-8138.2011.01278.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0016-6480(03)00092-3","article-title":"Cortisol treatment affects glucocorticoid receptor and glucocorticoid-responsive genes in the liver of rainbow trout","volume":"132","author":"Vijayan","year":"2003","journal-title":"General and Comparative Endocrinology"},{"key":"10.1111\/j.1346-8138.2011.01278.x-BIB13|cit13","first-page":"869","volume-title":"Textbook of Medical Physiology","author":"Guyton","year":"2000"},{"key":"10.1111\/j.1346-8138.2011.01278.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0065-2571(65)90041-5","article-title":"Glucocorticoid control of rat liver glutamic-alanine transaminase biosynthesis","volume":"3","author":"Segal","year":"1965","journal-title":"Adv Enzyme Regul"},{"issue":"11","key":"10.1111\/j.1346-8138.2011.01278.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1016\/S0021-9258(19)75332-0","article-title":"Glucocorticoids and transaminase activity","volume":"238","author":"Rosen","year":"1963","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"10.1111\/j.1346-8138.2011.01278.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1254\/jjp.46.247","article-title":"Liver injury model in mice for immunopharmacological study","volume":"46","author":"Nagai","year":"1988","journal-title":"The Japanese Journal of Pharmacology"},{"issue":"5","key":"10.1111\/j.1346-8138.2011.01278.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11938-004-0054-9","article-title":"Treatment of autoimmune hepatitis: current and future therapies","volume":"7","author":"Alvarez","year":"2004","journal-title":"Current Treatment Options in Gastroenterology"},{"issue":"9","key":"10.1111\/j.1346-8138.2011.01278.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2036.2005.02636.x","article-title":"Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease","volume":"22","author":"Bastida","year":"2005","journal-title":"Alimentary Pharmacology and Therapeutic"},{"issue":"9","key":"10.1111\/j.1346-8138.2011.01278.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/archderm.144.9.1143","article-title":"Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris","volume":"144","author":"Firooz","year":"2008","journal-title":"Archive of Dermatology"},{"issue":"3","key":"10.1111\/j.1346-8138.2011.01278.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10227-002-0113-6","article-title":"Mycophenolate mofetil (CellCept\u00ae) for psoriasis: a two-center, prospective, open- label clinical trial","volume":"7","author":"Hou","year":"2003","journal-title":"Journal of Cutaneous Medicine and Surgery"},{"issue":"2","key":"10.1111\/j.1346-8138.2011.01278.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0190-9622(99)70203-3","article-title":"Mycophenolate mofetil in autoimmune and inflammatory skin disorders","volume":"40","author":"Nousari","year":"1999","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1111\/j.1346-8138.2011.01278.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/clinchem\/47.1.88","article-title":"Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil","volume":"47","author":"Mourad","year":"2001","journal-title":"Clinical Chemistry"},{"issue":"3","key":"10.1111\/j.1346-8138.2011.01278.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1034\/j.1399-0012.2000.140301.x","article-title":"Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics","volume":"14","author":"Pescovitz","year":"2000","journal-title":"Clin Transpl"},{"key":"10.1111\/j.1346-8138.2011.01278.x-BIB24|cit24","volume-title":"Report: Cellcept","author":"Roche laboratories Inc","year":"2010"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1346-8138.2011.01278.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1346-8138.2011.01278.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T23:16:14Z","timestamp":1639091774000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1346-8138.2011.01278.x"}},"subtitle":["Hepatotoxicity in immunobullous diseases"],"short-title":[],"issued":{"date-parts":[[2011,10,10]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1346-8138.2011.01278.x","relation":{},"ISSN":["0385-2407"],"issn-type":[{"value":"0385-2407","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10,10]]}}}